De La Cruz Castor Oil

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
De La Cruz Castor Oil
Generic name
CASTOR OIL
Manufacturer
DLC Laboratories, Inc.
Product type
HUMAN OTC DRUG
SPL set ID
22fbad2e-e9fa-46ba-8617-ad79483cbe9a
SPL ID
377a5b4a-a015-ee13-e063-6394a90a2950
Version
14
Effective date
2025-06-13
Source export date
2026-09-28
Source partition
4
Source file
https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/c7ca0b7091cdaeab3f27713a6eef00adcf8fe722383633ddce61531b4c840544/drug-label-0004-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:25:08
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Do not use laxative products when abdominal pain, nausea, or vomiting are present unless directed by a doctor. for periods longer than a week. Frequent or prolonged use may result in dependence on laxatives. Ask a doctor before use if you have noticed a sudden change in bowel habits that persists over a period of two weeks. Ask a doctor or pharmacist before use if you are taking any other drug. Stop use and ask a doctor if you have rectal bleeding or failure to have a bowel movement after use of a laxative. These symptoms may indicate a serious condition. If pregnant or breast-feeding , ask a health professional before use. KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center immediately.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.